Vistagen Therapeutics, Inc. (VTGN) › Shares OutstandingVistagen Therapeutics, Inc. (VTGN) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 5.24M2012: 14.74M2013: 18.11M2014: 1.10M2015: 1.32M2016: 1.77M2023: 6.96M2024: 19.35M2025: 30.88M2026: 38.07M38.07M2011Shares Outstanding (shares)2026Fiscal YearShares OutstandingChange YoY202638.07M+23.3%202530.88M+59.5%202419.35M+178.1%20236.96M—20161.77M+34.1%20151.32M+20.0%20141.10M-93.9%201318.11M+22.9%201214.74M+181.2%20115.24M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share